Lista de obras - Charlotte G Nyvold - Dominio Público Uruguay

A decade with whole exome sequencing in haematology

scientific article published on 10 October 2019

A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma

artículo científico

A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia.

artículo científico publicado en 2013

A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease

artículo científico publicado en 2011

Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in theCEBPAgene in patients with acute myeloid leukaemia

artículo científico publicado en 2008

Cell sorting enables interphase fluorescence in situ hybridization detection of low BCR-ABL1 producing stem cells in chronic myeloid leukaemia patients beyond deep molecular remission.

artículo científico publicado en 2014

Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia

artículo científico publicado en 2013

Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment

scientific article published on 05 September 2018

Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology

artículo científico publicado en 2013

Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas

artículo científico publicado en 2014

Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab

artículo científico publicado en 2013

Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia

artículo científico publicado en 2000

Critical methodological factors in diagnosing minimal residual disease in hematological malignancies using quantitative PCR.

artículo científico publicado en 2015

Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.

artículo científico publicado en 2005

Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms.

artículo científico publicado en 2014

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

artículo científico publicado en 2011

Differential expression levels and methylation status of ROBO1 in mantle cell lymphoma and chronic lymphocytic leukaemia

artículo científico publicado en 2016

Erythropoietin receptor defect: a cause of primary polycythaemia.

artículo científico publicado en 2004

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories

artículo científico publicado en 2007

Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms.

artículo científico publicado en 2008

Interleukin-21 mRNA expression during virus infections

artículo científico publicado en 2006

Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.

artículo científico publicado en 2005

Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia

artículo científico publicado en 2013

Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.

artículo científico publicado en 2005

Multiplex PCR for the detection ofBCL-1/IGHandBCL-2/IGHgene rearrangements – clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma

scientific article published on 01 January 2007

Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations.

artículo científico publicado en 2015

Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research

artículo científico publicado en 2015

Post-induction residual disease in translocation t(12;21)-positive childhood ALL.

artículo científico publicado en 2003

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

artículo científico publicado en 2001

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

artículo científico publicado en 2002

Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.

artículo científico publicado en 2006

Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis.

artículo científico publicado en 2012

Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.

artículo científico publicado en 2008

Replicate whole-genome next-generation sequencing data derived from Caucasian donor saliva samples

publication published on 04 September 2021

SOX11 as a minimal residual disease marker for Mantle cell lymphoma

scientific article published on 28 April 2014

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?

scientific article published on 11 February 2015

Sensitive ligand-based protein quantification using immuno-PCR: A critical review of single-probe and proximity ligation assays

artículo científico publicado en 2014

Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation

artículo científico

The Mycoplasma hominis P120 membrane protein contains a 216 amino acid hypervariable domain that is recognized by the human humoral immune response.

artículo científico publicado en 1997

The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.

artículo científico publicado en 2009

WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder

artículo científico publicado en 2005

Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications

scientific article published on 21 September 2006

[Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation]

artículo científico publicado en 2009

[Molecular biology diagnosis and monitoring in acute lymphoblastic leukemia and non-Hodgkin-lymphoma]

scientific article published on 01 December 1996

hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia

artículo científico publicado en 2013

Lista de obras de Charlotte G Nyvold

A decade with whole exome sequencing in haematology

A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma

A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia.

A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease

Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in theCEBPAgene in patients with acute myeloid leukaemia

Cell sorting enables interphase fluorescence in situ hybridization detection of low BCR-ABL1 producing stem cells in chronic myeloid leukaemia patients beyond deep molecular remission.

Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia

Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment

Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology

Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas

Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab

Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia

Critical methodological factors in diagnosing minimal residual disease in hematological malignancies using quantitative PCR.

Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.

Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms.

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Differential expression levels and methylation status of ROBO1 in mantle cell lymphoma and chronic lymphocytic leukaemia

Erythropoietin receptor defect: a cause of primary polycythaemia.

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories

Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms.

Interleukin-21 mRNA expression during virus infections

Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.

Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia

Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.

Multiplex PCR for the detection ofBCL-1/IGHandBCL-2/IGHgene rearrangements – clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma

Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations.

Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research

Post-induction residual disease in translocation t(12;21)-positive childhood ALL.

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.

Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis.

Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.

Replicate whole-genome next-generation sequencing data derived from Caucasian donor saliva samples

SOX11 as a minimal residual disease marker for Mantle cell lymphoma

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?

Sensitive ligand-based protein quantification using immuno-PCR: A critical review of single-probe and proximity ligation assays

Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation

The Mycoplasma hominis P120 membrane protein contains a 216 amino acid hypervariable domain that is recognized by the human humoral immune response.

The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.

WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder

Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications

[Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation]

[Molecular biology diagnosis and monitoring in acute lymphoblastic leukemia and non-Hodgkin-lymphoma]

hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia